These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 34625780)
1. Seroprevalence of SARS-CoV-2 IgG antibodies among workers in the University Hospital of Guadeloupe. Palmeri V; Le Turdu-Chicot C; Garin B; Auguste A; Roger PM Clin Ter; 2021 Sep; 172(5):461-466. PubMed ID: 34625780 [TBL] [Abstract][Full Text] [Related]
2. Seroprevalence study of SARS-CoV-2 antibodies in healthcare workers following the first wave of the COVID-19 pandemic in a tertiary-level hospital in the south of Ireland. Faller E; Wyse A; Barry R; Conlon K; Everard C; Finnegan P; Foran C; Herlihy E; Kerr G; Lapthorne S; McGreal-Bellone A; Morrissey E; O'Sullivan D; O'Sullivan G; Eustace JA; Spillane D; Dempsey C; Benson J; Prentice M; Gallagher J; MacSharry J; Fanning LJ; O'Riordan S; Horgan M; Sadlier C BMJ Open; 2021 Jun; 11(6):e051415. PubMed ID: 34103324 [TBL] [Abstract][Full Text] [Related]
3. Higher rate of SARS-CoV-2 IgG seropositivity in hospital-based healthcare workers compared to elderly care staff in a Swedish low-prevalence region: a cross-sectional study. Ocias LF; Skogstam A; Kjerstadius T; Lundin F; Tevell S Infect Dis (Lond); 2021; 53(12):920-929. PubMed ID: 34350813 [TBL] [Abstract][Full Text] [Related]
4. [SARS-CoV-2 Seroprevalence Among Healthcare Workers: Retrospective Analysis of the Data From A University Hospital in Turkey]. Özdemir A; Demir Çuha M; Telli Dizman G; Alp A; Metan G; Şener B Mikrobiyol Bul; 2021 Apr; 55(2):223-232. PubMed ID: 33882653 [TBL] [Abstract][Full Text] [Related]
6. The reliability of SARS-CoV-2 IgG antibody testing - a pilot study in asymptomatic health care workers in a Croatian university hospital. Lapić I; Rogić D; Šegulja D; Kralik Oguić S; Knežević J Croat Med J; 2020 Dec; 61(6):485-490. PubMed ID: 33410294 [TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India. Gupta R; Dwivedi T; Gajendra S; Sahoo B; Gupta SK; Vikas H; Singh AR; Mohan A; Bhatnagar S; Singh S; Wundavalli L; Guleria R Indian J Med Res; 2021 Jan & Feb; 153(1 & 2):207-213. PubMed ID: 33642348 [TBL] [Abstract][Full Text] [Related]
8. Half-Year Longitudinal Seroprevalence of SARS-CoV-2-Antibodies and Rule Compliance in German Hospital Employees. Herzberg J; Vollmer T; Fischer B; Becher H; Becker AK; Sahly H; Honarpisheh H; Guraya SY; Strate T; Knabbe C Int J Environ Res Public Health; 2021 Oct; 18(20):. PubMed ID: 34682719 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study. Stefanelli P; Bella A; Fedele G; Pancheri S; Leone P; Vacca P; Neri A; Carannante A; Fazio C; Benedetti E; Fiore S; Fabiani C; Simmaco M; Santino I; Zuccali MG; Bizzarri G; Magnoni R; Benetollo PP; Merler S; Brusaferro S; Rezza G; Ferro A Clin Microbiol Infect; 2021 Apr; 27(4):633.e1-633.e7. PubMed ID: 33253941 [TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of SARS-CoV-2 in healthcare workers from outpatient facilities and retirement or nursing homes in a Swiss canton. Zürcher K; Mugglin C; Suter-Riniker F; Keller PM; Egger M; Müller S; Fluri M; Hoffmann M; Fenner L Swiss Med Wkly; 2021 Aug; 151():w30021. PubMed ID: 34495604 [TBL] [Abstract][Full Text] [Related]
11. [SARS-CoV-2 seroprevalence among workers in a hospital in Madrid.]. Pérez-García F; Pérez-Zapata A; Arcos Varela N; de la Mata Herrera M; Ortiz García M; Simón Ramos E; Calero Barzano C; Clemente García B; García Miranda L; Martín Soto L; Ropero Martínez M; Barrabés Bayascas RM; Cuadros-González J Rev Esp Salud Publica; 2021 Oct; 95():. PubMed ID: 34675168 [TBL] [Abstract][Full Text] [Related]
12. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?]. Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F; Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland. Kasztelewicz B; Janiszewska K; Burzyńska J; Szydłowska E; Migdał M; Dzierżanowska-Fangrat K PLoS One; 2021; 16(4):e0249550. PubMed ID: 33793673 [TBL] [Abstract][Full Text] [Related]
14. Retrospective analysis of seroprevalence in a cohort of university students of Rome (Italy) between September 2020 and July 2021. Ulivieri A; Morgante A; Magi F; Salehi LB; Lavra L Epidemiol Prev; 2022; 46(5-6):367-375. PubMed ID: 36628641 [TBL] [Abstract][Full Text] [Related]
15. Assessment of initial SARS-CoV-2 seroprevalence in the most affected districts in the municipality of São Paulo, Brazil. Tess BH; Granato CFH; Alves MCGP; Pintão MCT; Nunes MC; Rizzatti EG; Reinach FC Braz J Infect Dis; 2021; 25(4):101604. PubMed ID: 34416142 [TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 seroprevalence in hospital healthcare workers in Western Switzerland at the end of the second pandemic wave. Jacot D; von Rotz U; Blondet F; Aebischer O; Matthieu P; De Rham M; Pantaleo G; Marchetti O; Greub G J Med Microbiol; 2022 Aug; 71(8):. PubMed ID: 35921229 [No Abstract] [Full Text] [Related]
17. SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic. Pereckaitė L; Dambrauskienė A; Urbonienė D; Sadauskas S; Petrikonis K; Naudžiūnas A; Vitkauskienė A Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562085 [No Abstract] [Full Text] [Related]
18. Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave. Barallat J; Fernández-Rivas G; Quirant-Sánchez B; González V; Doladé M; Martinez-Caceres E; Piña M; Matllo J; Estrada O; Blanco I PLoS One; 2020; 15(12):e0244348. PubMed ID: 33370363 [TBL] [Abstract][Full Text] [Related]
19. Prospective surveillance study in a 1,400-bed university hospital: COVID-19 exposure at home was the main risk factor for SARS-CoV-2 point seroprevalence among hospital staff. Bahrs C; Kimmig A; Weis S; Ankert J; Hagel S; Maschmann J; Stallmach A; Steiner A; Bauer M; Behringer W; Baier M; Kesselmeier M; Richert C; Zepf F; Walter M; Scherag A; Kiehntopf M; Löffler B; Pletz MW Transbound Emerg Dis; 2022 Mar; 69(2):720-730. PubMed ID: 33605549 [TBL] [Abstract][Full Text] [Related]